Aelis’ technology could overcome this hurdle by mimicking the action of pregnenolone, a steroid that activates only one of CB1’s pathways to specifically reduce behavior related to cannabis addiction. CB1 receptors are widespread and involved in a lot of different diseases. Because of this, Aelis’ sees … Read More
The post French Biotech Targets the Brain to Treat Cannabis Abuse appeared first on Dagga Magazine.